“In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis” (2018) ADMET and DMPK, 6(2), pp. 176–189. doi:10.5599/admet.547.